Skip to Content

APO F130 (Fenofibrate (Micronized) 130 mg)

Pill with imprint APO F130 is Green & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 130 mg. It is supplied by Apotex Corp..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO F130

Fenofibrate (micronized) 130 mg APO F130
Fenofibrate (micronized) 130 mg APO F130
Fenofibrate (micronized) 130 mg APO F130

Fenofibrate (Micronized)

Imprint
APO F130
Strength
130 mg
Color
Green & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-3121

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.